Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy

  • Matthew Greenhawt
  • , Sayantani b. Sindher
  • , Julie Wang
  • , Michael O’sullivan
  • , George Du toit
  • , Edwin h. Kim
  • , Deborah Albright
  • , Sara Anvari
  • , Nicolette Arends
  • , Peter d. Arkwright
  • , Philippe Bégin
  • , Katharina Blumchen
  • , Thierry Bourrier
  • , Terri Brown-Whitehorn
  • , Heather Cassell
  • , Edmond s. Chan
  • , Christina e. Ciaccio
  • , Antoine Deschildre
  • , Amandine Divaret-Chauveau
  • , Stacy l. Dorris
    • Morna j. Dorsey, Thomas Eiwegger, Michel Erlewyn-Lajeunesse, David m. Fleischer, Lara s. Ford, Maria Garcia-Lloret, Lisa Giovannini-Chami, Jonathan o. Hourihane, Nicola Jay, Stacie m. Jones, Leigh ann Kerns, Kirsten m. Kloepfer, Stephanie Leonard, Guillaume Lezmi, Jay a. Lieberman, Jeanne Lomas, Melanie Makhija, Christopher Parrish, Jane Peake, Kirsten p. Perrett, Daniel Petroni, Wolfgang Pfützner, Jacqueline a. Pongracic, Patrick Quinn, Rachel g. Robison, Georgiana Sanders, Lynda Schneider, Hemant p. Sharma, Juan Trujillo, Paul j. Turner, Katherine Tuttle, Julia e. Upton, Pooja Varshney, Brian p. Vickery, Christian Vogelberg, Brynn Wainstein, Robert a. Wood, Katharine j. Bee, Dianne e. Campbell, Todd d. Green, Rihab Rouissi, Aurélie Peillon, Henry t. Bahnson, Timothée Bois, Hugh a. Sampson, A. wesley Burks

Research output: Journal article (peer-reviewed) › Journal article

106 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology